Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05190341 · ClinicalTrials.gov registry record · Phase 4
Ibuprofen Versus Ketorolac for Pain Relief During Hysterosalpingogram
A Phase 4 study, sponsored by Madigan Army Medical Center.
- Terminated
- Registry status
- Phase 4
- Development phase
- 12
- Enrollment target
NCT05190341: Clinical Trial Phase 4 study, sponsored by Madigan Army Medical Center.
NCT05190341 is a Phase 4 study that was terminated before completion, run by Madigan Army Medical Center. The registered enrollment target is 12 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05190341, a Phase 4 study, was terminated before completion, sponsored by Madigan Army Medical Center.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 12 participants
- Enrollment target
Study Summary
Hysterosalpingogram (HSG) testing is a vital part of the workup for infertility patients. It is often noted to be biggest pain that patients undergo during the workup. Several studies have attempted to find a therapy that reduces pain, with non-steroidal anti-inflammatory drugs such as oral ibuprofen the current mainstay. Our study attempts to determine which of the following NSAIDS is best at reducing pain associated with the HSG procedure: oral ibuprofen versus oral ketorolac .
Primary Outcome
Pain on Visual Analogue Scale (0-100)
Interventions
- DRUG Ibuprofen 800 mg oral
- DRUG Ketorolac 30mg oral
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2022-03-24 |
| Est. Completion | 2024-10-10 |
| Phase | Phase 4 |
Why NCT05190341 stopped before completion
NCT05190341 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Ibuprofen 800 mg oral is the first listed.
NCT05190341 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05190341 about?
NCT05190341 is a clinical study titled "Ibuprofen Versus Ketorolac for Pain Relief During Hysterosalpingogram". Hysterosalpingogram (HSG) testing is a vital part of the workup for infertility patients. It is often noted to be biggest pain that patients undergo during the workup. Several studies have attempted to find a therapy that reduces pain, with non-steroidal anti-inflammatory drugs such as oral ibuprofe...
What is the current status of trial NCT05190341?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 12 participants. The study started on 2022-03-24. Estimated completion is 2024-10-10.
What interventions are being tested in trial NCT05190341?
The interventions under investigation include: Ibuprofen 800 mg oral (DRUG), Ketorolac 30mg oral (DRUG).
Who is sponsoring clinical trial NCT05190341?
This trial is sponsored by Madigan Army Medical Center, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05190341's enrollment target sits among peer trials
12 1913th of 2000 higher than 70 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI